Search Results
ANTIPLATELETS AND NOACS - USE IN DIABETES
Warfarin versus the NOACs for the treatment of atrial fibrillation
Newer Anticoagulants in Atrial Fibrillation: Should I Incorporate Them Into Clinical Practice?
The New Anticoagulants in Cardiovascular Disease: Atrial Fibrillation and Beyond
NOAC vs Warfarin, Current Status of Venous Anticoagulation (Baltazar MD; Petkova MD) March 24, 2021
EHRA free webinar: Use of oral anticoagulants in AF patients undergoing cardioversion
The conundrum of antithrombotic therapy in atrial fibrillation patients undergoing TAVI-EuroPCR 2022
2017 Spring Symposium: Oral Anticoagulants
Antiplatelet/NOAC Therapy is associated with worse outcomes after suprainguinal bypass
Optimizing Antiplatelet Therapy in Diabetes Mellitus | Dominick J. Angiolillo
Anticoagulation - It Doesn't Have to be a Bleeding Nightmare
Stroke Prevention in Atrial Fibrillation